Letter to the Editor: Comment on "SGLT2 inhibitors may predispose to ketoacidosis" by Taylor S.I., et al

J Clin Endocrinol Metab. 2016 Feb;101(2):L27-8. doi: 10.1210/jc.2015-4236.

Author

Lakshman Segar¹

Affiliation

¹ Center for Pharmacy and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, Georgia 30912; Charlie Norwood Veterans Affairs Medical Center, August, Georgia 30912; Vascular Biology Center, Department of Pharmacology and Toxicology, Georgia Regents University, Augusta, Georgia 30912; and Department of Medicine, Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033.

PMID: 26840113
DOI: 10.1210/jc.2015-4236

No abstract available

Publication types

Letter
Comment

MeSH terms

Diabetic Ketoacidosis / chemically induced*
Humans
Hypoglycemic Agents / adverse effects*
Sodium-Glucose Transporter 2 Inhibitors*

Substances

Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors